In the last trading session, 1.02 million Vigil Neuroscience Inc (NASDAQ:VIGL) shares changed hands as the company’s beta touched 1.76. With the company’s per share price at $1.78 changed hands at $0.04 or 2.30% during last session, the market valuation stood at $72.77M. VIGL’s last price was a discount, traded about -240.45% off its 52-week high of $6.06. The share price had its 52-week low at $1.49, which suggests the last value was 16.29% up since then. When we look at Vigil Neuroscience Inc’s average trading volume, we note the 10-day average is 0.24 million shares, with the 3-month average coming to 223.23K.
Analysts gave the Vigil Neuroscience Inc (VIGL) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.44. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended VIGL as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Vigil Neuroscience Inc’s EPS for the current quarter is expected to be -0.47.
Vigil Neuroscience Inc (NASDAQ:VIGL) trade information
Instantly VIGL was in green as seen at the end of in last trading. With action -1.11%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 4.71%, with the 5-day performance at -1.11% in the red. However, in the 30-day time frame, Vigil Neuroscience Inc (NASDAQ:VIGL) is -18.72% down. Looking at the short shares, we see there were 0.51 million shares sold at short interest cover period of 5.31 days.
The consensus price target for the stock as assigned by Wall Street analysts is 11, meaning bulls need an upside of 83.82% from its current market value. According to analyst projections, VIGL’s forecast low is 11 with 11 as the target high. To hit the forecast high, the stock’s price needs a -517.98% plunge from its current level, while the stock would need to soar -517.98% for it to hit the projected low.
Vigil Neuroscience Inc (VIGL) estimates and forecasts
Data shows that the Vigil Neuroscience Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -57.62% over the past 6 months, a 2.82% in annual growth rate that is considerably lower than the industry average of 16.70%.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
The 2025 estimates are for Vigil Neuroscience Inc earnings to increase by 4.38%.
VIGL Dividends
Vigil Neuroscience Inc is expected to release its next quarterly earnings report in February.
Vigil Neuroscience Inc (NASDAQ:VIGL)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 21.27% of Vigil Neuroscience Inc shares while 80.16% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 101.81%. There are 80.16% institutions holding the Vigil Neuroscience Inc stock share, with ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC the top institutional holder. As of 2024-06-30, the company held 14.6419% of the shares, roughly 5.84 million VIGL shares worth $23.35 million.
NORTHPOND VENTURES, LLC holds the second largest percentage of outstanding shares, with 10.5722% or 4.21 million shares worth $16.86 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and abrdn Life Sciences Investors . With 710.14 shares estimated at $1.26 million under it, the former controlled 1.74% of total outstanding shares. On the other hand, abrdn Life Sciences Investors held about 0.57% of the shares, roughly 235.01 shares worth around $0.42 million.
